The nephroprotective effects of Daucus carota and Eclipta prostrata against cisplatin-induced nephrotoxicity in rats

Bioengineered. 2021 Dec;12(2):12702-12721. doi: 10.1080/21655979.2021.2009977.

Abstract

The overuse of cisplatin (>50 mg/m2) is limited to nephrotoxicity, ototoxicity, gastrotoxicity, myelosuppression, and allergic reactions. The objective of this study was to investigate the nephroprotective effects of Daucus carota and Eclipta prostrata extracts on cisplatin-induced nephrotoxicity in Wistar albino rats. The study involved male Wistar albino rats of 8 weeks weighing 220-270 g. A single injection of 5 mg/kg was injected into the rats for nephrotoxicity. Rats were divided into four groups based on dose conentrations. Blood and urine samples of rats were collected on the 0, 7th, 14th, and 21st days for nephrological analysis. The results showed that Cis + DC/Cis + EP (600 mg/kg) significantly (p < 0.001) increased the body weight and reduced the kidney weight of cisplatin-induced nephrotoxicity in rats (p < 0.001) as compared to Cis group. The results showed that 600 mg/kg administration of Cis + DC/Cis +EP successfully (p < 0.005) improved the urine and plasmin creatinine, Na, and K level compared to the Cis group. Histopathological results confirmed that Cis + EP/Cis + DC effectively improved the renal abnormalities. It is concluded that the co-administration of Cis + EP extract showed exceptional nephroprotective effects at a dose rate of 600 mg/kg.

Keywords: Cisplatin; Daucus carota; Eclipta prostrata; nephroprotection; nephrotoxicity; rats.

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Cisplatin / adverse effects*
  • Creatinine / blood
  • Daucus carota / chemistry*
  • Eclipta / chemistry*
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney Diseases / blood
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / urine
  • Male
  • Organ Size / drug effects
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Potassium / urine
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use*
  • Rats
  • Rats, Wistar
  • Sodium / urine
  • Urination / drug effects

Substances

  • Plant Extracts
  • Protective Agents
  • Sodium
  • Creatinine
  • Cisplatin
  • Potassium

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.